Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 9
1986 11
1987 4
1988 5
1989 3
1990 2
1991 4
1992 2
1993 1
1994 4
1995 2
1996 1
1999 1
2001 6
2002 3
2003 5
2004 2
2005 3
2006 2
2007 5
2008 6
2009 11
2010 14
2011 7
2012 13
2013 13
2014 18
2015 22
2016 17
2017 19
2018 19
2019 16
2020 20
2021 17
2022 27
2023 18
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Results by year

Filters applied: . Clear all
Page 1
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.
Fry TJ, Shah NN, Orentas RJ, Stetler-Stevenson M, Yuan CM, Ramakrishna S, Wolters P, Martin S, Delbrook C, Yates B, Shalabi H, Fountaine TJ, Shern JF, Majzner RG, Stroncek DF, Sabatino M, Feng Y, Dimitrov DS, Zhang L, Nguyen S, Qin H, Dropulic B, Lee DW, Mackall CL. Fry TJ, et al. Among authors: sabatino m. Nat Med. 2018 Jan;24(1):20-28. doi: 10.1038/nm.4441. Epub 2017 Nov 20. Nat Med. 2018. PMID: 29155426 Free PMC article. Clinical Trial.
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, Fry TJ, Orentas R, Sabatino M, Shah NN, Steinberg SM, Stroncek D, Tschernia N, Yuan C, Zhang H, Zhang L, Rosenberg SA, Wayne AS, Mackall CL. Lee DW, et al. Among authors: sabatino m. Lancet. 2015 Feb 7;385(9967):517-528. doi: 10.1016/S0140-6736(14)61403-3. Epub 2014 Oct 13. Lancet. 2015. PMID: 25319501 Free PMC article. Clinical Trial.
Editorial: Architects of Endocrine-Related Tumour Growth.
Sabatino ME, Díaz-Torga G, De Paul AL. Sabatino ME, et al. Front Endocrinol (Lausanne). 2022 Oct 24;13:1046478. doi: 10.3389/fendo.2022.1046478. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36353237 Free PMC article. No abstract available.
Architects of Pituitary Tumour Growth.
Sabatino ME, Grondona E, De Paul AL. Sabatino ME, et al. Front Endocrinol (Lausanne). 2022 Jun 28;13:924942. doi: 10.3389/fendo.2022.924942. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35837315 Free PMC article. Review.
Risk Adjustment And Health Equity.
Sabatino M, Alcusky MJ, Mick EO, Ash AS. Sabatino M, et al. Health Aff (Millwood). 2023 May;42(5):732. doi: 10.1377/hlthaff.2023.00218. Health Aff (Millwood). 2023. PMID: 37126748 No abstract available.
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.
Nowak RP, Tumber A, Hendrix E, Ansari MSZ, Sabatino M, Antonini L, Andrijes R, Salah E, Mautone N, Pellegrini FR, Simelis K, Kawamura A, Johansson C, Passeri D, Pellicciari R, Ciogli A, Del Bufalo D, Ragno R, Coleman ML, Trisciuoglio D, Mai A, Oppermann U, Schofield CJ, Rotili D. Nowak RP, et al. Among authors: sabatino m. J Med Chem. 2021 Dec 9;64(23):17031-17050. doi: 10.1021/acs.jmedchem.1c00605. Epub 2021 Nov 29. J Med Chem. 2021. PMID: 34843649 Free PMC article.
295 results